Safety and Efficacy Study of Microplasmin in for Non-Surgical Treatment of Focal Vitreomacular Adhesion
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the safety and efficacy of Microplasmin administered as an
intravitreal injection, in subjects with focal vitreomacular adhesion. Ultimately, it is
believed that intravitreal microplasmin may offer physicians a safe agent for pharmacologic
vitreolysis and induction of Posterior Vitreous Detachment (PVD) without the need for
vitrectomy. This clinical study is justified because the study sponsor believes the potential
benefits outweigh the potential risks, as outlined below.